These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4146591)

  • 1. Antagonistic actions of alpha-methylnoradrenaline derived from alpha-methyldopa.
    Boakes RJ; Candy JM; Wolstencroft JH
    J Pharm Pharmacol; 1973 Jun; 25(6):491-2. PubMed ID: 4146591
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 3. The significance of the relative potencies of norepinephrine and alpha-methylnoradrenaline for the mode of action of alpha-methyldopa.
    Trinker FR
    J Pharm Pharmacol; 1971 Apr; 23(4):306-8. PubMed ID: 4396912
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of alpha-methyl DOPA and alpha-methylnoradrenaline.
    Kadzielawa K
    Act Nerv Super (Praha); 1965 Aug; 7(3):277-8. PubMed ID: 5882113
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the formation of alpha-methylnoradrenaline in hypertensive patients treated with alpha-methyldopa.
    Muscholl E; Rahn KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):215-6. PubMed ID: 4232699
    [No Abstract]   [Full Text] [Related]  

  • 6. An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations.
    Gulati OD; Parikh HM; Ringe SY; Sherlekar ML
    Br J Pharmacol; 1970 Dec; 40(4):689-701. PubMed ID: 5495174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonistic and antagonistic effects of alpha-methylnoradrenaline at central receptors.
    Boakes RJ; Candy JM; Wolstencroft JH
    Brain Res; 1968 Nov; 11(2):450-2. PubMed ID: 5701208
    [No Abstract]   [Full Text] [Related]  

  • 8. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between the cardiovascular effects of alpha-methyldopa and its metabolism in pontomedullary noradrenergic neurons of the rabbit.
    Bobik A; Oddie C; Scott P; Mill G; Korner P
    J Cardiovasc Pharmacol; 1988 May; 11(5):529-37. PubMed ID: 2455838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular activity of alpha methyldopa metabolites in the dog].
    Wepierre J; Doreau C; Papin A; Paultre C; Cohen Y
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):135-49. PubMed ID: 4149582
    [No Abstract]   [Full Text] [Related]  

  • 11. Actions of noradrenaline, other sympathomimetic amines and antagonists on neurones in the brain stem of the cat.
    Boakes RJ; Bradley PB; Brookes N; Candy JM; Wolstencroft JH
    Br J Pharmacol; 1971 Mar; 41(3):462-79. PubMed ID: 5576254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Formation and storage of alpha-methylnoradrenaline].
    Philippu A; Schümann HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):183-95. PubMed ID: 4232999
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat.
    Clarke DE; Leach GD
    Br J Pharmacol Chemother; 1968 Feb; 32(2):392-401. PubMed ID: 4384657
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective stimulation of central alpha-autoreceptors following treatment with alpha-methyldopa and FLA 136.
    Andén NE
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):263-6. PubMed ID: 38408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central hypotensive action of alpha-methyldopa: an iontophoretic study in the cat.
    Sharma JN; Sandrew BB; Wang SC
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):92-9. PubMed ID: 526073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rest and physical activity on the urinary excretion of noradrenaline and alpha-methylnoradrenaline in human subjects treated with alpha-methyldopa.
    Lindmar R; Muscholl E; Rahn KH
    Eur J Pharmacol; 1968 Feb; 2(4):317-9. PubMed ID: 5642036
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the pharmacology of alpha-methyl-3,4-dihydroxyphenylalanine (alpha-methyl-dopa) and alpha-methylnorepinephrine. II.
    Kadzielawa K
    Int J Neuropharmacol; 1967 Nov; 6(6):453-62. PubMed ID: 5300898
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of alpha-methyldopa and its metabolites on the preferential liberation of newly synthesized 3H noradrenaline].
    Cohen Y; Rapin J; Jacquot C; Hamar C
    C R Acad Hebd Seances Acad Sci D; 1973 Oct; 277(15):1581-3. PubMed ID: 4204872
    [No Abstract]   [Full Text] [Related]  

  • 19. [Excretion of alpha-methylnoradrenaline in the urine of hypertensive patients during treatment with alpha-methyldopa].
    Muscholl E; Rahn KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):44-5. PubMed ID: 4231857
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methyldopa in the therapy of hypertension].
    Hilden T; Nilsson R
    Tidsskr Nor Laegeforen; 1968 Jul; 88(14):1416-20. PubMed ID: 5699219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.